MUHAS and Dartmouth TB Vaccine Moves Forward After Successful Phase 2 Trial Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine from a three-year trial in Tanzania were announced by investigators at Dartmouth’s Geisel School of Medicine…

The 2nd National Non-Communicable Diseases (NCD) Conference 2020 at JNICC Please fill out this evalution form for the 2nd NCD Conference 2020. Thank you.